Physician profile
Patrick C Murray
NPI 1982748356
$19,488.17
in general payments reported to CMS, 2019-2025
15 companies · $661 in 2025
The $661 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,186 · 2020: $2,404 · 2021: $3,277 · 2022: $3,871 · 2023: $629 · 2024: $3,460 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,815 · Travel and Lodging: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,815.40 |
| Travel and Lodging | $934.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12,737.47 | 2019-2023 | Prevena |
| Trimed, INC. | $2,801.30 | 2024 | |
| Smith+Nephew, INC. | $1,237.95 | 2019-2022 | |
| Si-Bone, INC. | $1,006.45 | 2022-2025 | |
| Bioventus LLC | $507.14 | 2021-2025 | Durolane, Durolane, Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $316.01 | 2021-2024 | |
| Osteocentric Technologies, INC. | $208.47 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Solventum Corporation | $175.73 | 2024-2025 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Avita Medical Americas, LLC | $174.25 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Highridge Medical LLC | $118.73 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| My01 INC. | $112.89 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Orthogenrx INC. | $30.42 | 2019 | |
| Osiris Therapeutics INC. | $23.06 | 2019 | |
| Avanos Medical | $19.27 | 2024 | Genvisc 850 Sodium Hyaluronate |
| Amgen INC. | $19.03 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.